High expression of some CD44 splice forms have been reported to associate with a poor prognosis and shorter survival in AML patients, although it remains unclear the CD44 ligands involved (Legras et al., 1998; Thapa and Wilson, 2016). This evidence concerns the gene CD44 and acute myeloid leukemia.